Back to Newsroom
Back to Newsroom

Saudi Arabia Pharmaceutical Market is Predicted to be Worth US$ 13 Bn by the End of Year 2032 - Explore Key Data Analysis & Growth Factors by Future Market Insights, Inc.

Monday, October 24, 2022 3:00 AM
Future Market Insights, Inc.
https://www.futuremarketinsights.com/

Saudi Arabia's government and multinational corporations are working to improve the healthcare sector, which is likely to boost the growth of the Saudi Arabia pharmaceutical market throughout the forecast period.

NEWARK, DE / ACCESSWIRE / October 24, 2022 / As per Future Market Insights' latest industry analysis, The global Saudi Arabia pharmaceutical market is anticipated to create a phenomenal opportunity by exhibiting an impressive CAGR of 9.6% over the projection period from 2022 to 2032. The market is expected to hold a valuation worth US$ 5,209.5 Million by the end of 2022.

Future Market Insights, Inc., Monday, October 24, 2022, Press release picture

The growth of Saudi Arabia's pharmaceutical market is predicted to continue to propel over the estimation period owing to the country's fast-rising population and large intake of expatriates. The Saudi pharmaceutical business is dominated by branded pharmaceuticals produced by numerous global corporations and sold under a second brand name in collaboration with local firms and distributors. Pharmaceutical demand is rapidly surging in Saudi Arabia attributed to the increase in the frequency of non-communicable illnesses and better healthcare infrastructure.

Saudi Arabia imports around 80% of its medications from several other nations, and the country's market is dominated by several global corporations. Surging lifestyle illnesses and high brand loyalty for multinational medications in Saudi Arabia are likely to bolster pharmaceutical demand throughout the predicted period. In addition to that, surging per capita income, expanding healthcare infrastructure, and increased penetration of health insurance firms in the Kingdom are fueling development in the Saudi pharmaceutical industry. In Saudi Arabia, MNCs dominate the pharmaceuticals market resulting in accounting for the lion's share of the market.

Get a Sample Copy of [email protected]
https://www.futuremarketinsights.com/reports/sample/rep-gc-1733

The Saudi Arabia pharmaceutical market is anticipated to witness phenomenal growth due to rising health consciousness and increased healthcare spending is projected to bolster market expansion in the upcoming years. Macroeconomic reasons such as increased health insurance company penetration and healthcare reforms such as permitting 100% FDI in the pharmaceuticals industry are also expected to fuel market expansion. Several other significant developments in the marking include the fast-expanding number of religious visitors and the growing number of ex-pats in the nation.

Saudi Arabia is known as the largest market in the GCC area that offers superior investment options for investors, which are driven by mandated insurance for ex-pats in the nation. These aforementioned factors are responsible for growth in the Saudi Arabia pharmaceutical market across the forecast period.

Key Takeaways

  • Saudi Arabia's government and other multinational organizations are meticulously working towards improving their healthcare sector which is one of the key drivers to boost the growth of the Saudi Arabia pharmaceutical market throughout the forecast period. The Saudi Arabian General Investment Authority (SAGIA) and the British pharmaceutical company GlaxoSmithKline inked a manufacturing localization agreement in July 2019, (GSK). This is projected to help the latter accelerate its production capacity by 2022, producing a variety of Saudi-related employment.
  • The dominant businesses actively participating in the Saudi Arabia pharmaceutical market are focusing on effective business tactics such as drug development collaborations and partnerships, R&D activities, and regional expansions, which are projected to enhance the Saudi Arabia pharmaceutical market growth.
  • Owing to the rising prevalence of diabetes and cancer in both males and females among the Arab population is predicted to bolster the Saudi Arabia pharmaceuticals market throughout the forecast period. As per the projections of the World Health Organization (WHO), Saudi Arabia comprises the second-largest diabetes prevalence rate in the Middle East region and the seventh-highest diabetes prevalence rate in the world. It is analyzed that around 7 million individuals are diabetic, with an additional 3 million having pre-diabetes.

For any Queries Linked with the Report, Ask an [email protected]
https://www.futuremarketinsights.com/ask-question/rep-gc-1733

Competitive Landscape

Dominant market players are focusing on innovations that are driving the most recent advances in Saudi Arabia's pharmaceutical sector. The country has managed to become one of the world's top-rising economies on the basis of entrepreneurship and business.

More Insights into theSaudi Arabia Pharmaceutical Market

The Saudi Arabia pharmaceutical market has been classified into cardiovascular diseases, diabetes, cancer, obesity, infectious diseases, and other diseases. The cardiovascular disease sector is predicted to expand the most throughout the projection period, followed by the diabetes segment. Because of increased comorbidities such as cardiovascular disease and diabetes, the obesity segment is predicted to rise significantly.

Key Segments Covered in the Saudi Arabia Pharmaceutical Industry Analysis

Saudi Arabia Pharmaceutical Market by Product Type:

  • Prescription Products
    • Branded Drugs
    • Generic Drugs
  • Over The Counter (OTC) Products

Saudi Arabia Pharmaceutical Market by Disease Type:

  • Cardiovascular Diseases
  • Diabetes
  • Cancer
  • Obesity
  • Infectious Diseases
  • Other Diseases

Saudi Arabia Pharmaceutical Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies

Click on the Below Link to Buy this [email protected]
https://www.futuremarketinsights.com/checkout/1733

Table of Content

1. Research Methodology

2. Assumptions & Acronyms

3. Executive Summary

4. Saudi Arabia Pharmaceutical Market Overview

4.1. Definition

4.2. GCC Pharmaceutical Market Overview

4.3. Value Chain Analysis

4.4. Trade Associations and Trade Fairs

4.5. PESTLE Analysis

4.6. Saudi Arabia Pharmaceuticals Market Overview, 2022-2032

5. Saudi Arabia Pharmaceutical Market-Healthcare Indicators

5.1. Macroeconomic Indicators

5.1.1. Saudi Arabia GDP (US$ Bn) and GDP Growth (%)

5.1.2. GDP Growth (%) Comparison

5.1.3. Healthcare Expenditure (% of GDP), Saudi Arabia

5.1.4. Healthcare Expenditure (% of GDP) Comparison, 2022

Browse Full Report @ https://www.futuremarketinsights.com/reports/saudi-arabia-pharmaceutical-market

Have a Look at Related Research Reports of Healthcare

Antibiotics Active Pharmaceutical Ingredient (API) Market Size: Antibiotics Active Pharmaceutical Ingredient (API) Market demand to grow at 3.1% CAGR through 2030. The increasing antibiotics consumption has been fueling the demand

Anti-Neoplastic Pharmaceutical Agents Market Sales: Anti-Neoplastic Pharmaceutical Agents Market - Global industry segment analysis, regional outlook, share, growth; anti-neoplastic pharmaceutical agents market forecast 2016 to 2026 by future market insights

Specialty Active Pharmaceutical Ingredients Market Trends: Specialty active pharmaceutical ingredients (API) market likely to grow at over 7.0 % in 2020, as increasing patent expiry of various branded drugs boosts generics sales in the US and Europe

Pharmaceutical E-commerce Market Share: The global pharmaceutical E-commerce market is estimated to reach US$ 72.1 Bn in 2022

Pharmaceuticals Excipients Market Outlook: The pharmaceuticals excipients market is expected to register a CAGR of 6% during the forecast period, up from US$ 7.9 Bn in 2021 to reach a valuation of US$ 10.9 Bn by 2026

Softgel Capsules Market Sales: The global softgel capsules market is expected to enjoy a valuation of US$ 1.7 Bn by the end of the year 2022

Pharmaceutical Drug Delivery Market Value: During the assessment period, the global Pharmaceutical Drug Delivery Market is expected to increase at a robust CAGR of 6%, from US$ 1600 Bn in 2021 to US$ 3000 Bn by 2032

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact:
Future Market Insights Inc. 
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA 
T: +1-845-579-5705 
For Sales Enquiries: [email protected]

SOURCE: Future Market Insights Inc. 

Topic:
Company Update
Back to newsroom
Back to Newsroom